Q2 2024 Holdings
Filed 2024-08-14 | 83 holdings | $418.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $41.3M | 445,005 | 9.9% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $24.9M | 13,680,554 | 5.9% |
| Merus N V | COM | N5749R100 | $24.2M | 409,445 | 5.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $21.6M | 398,100 | 5.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $19.9M | 511,894 | 4.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $14.8M | 422,213 | 3.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $14.6M | 639,173 | 3.5% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $14.1M | 102,500 | 3.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $13.5M | 657,074 | 3.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.3M | 104,763 | 2.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.0M | 80,972 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.7M | 273,739 | 2.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $10.0M | 189,117 | 2.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.9M | 71,615 | 2.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $9.5M | 806,973 | 2.3% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.2M | 666,463 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.7M | 423,500 | 2.1% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $8.2M | 204,208 | 2.0% |
| Morphic Holding Inc | COM | 61775R105 | $7.9M | 231,748 | 1.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $7.9M | 469,000 | 1.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.6M | 218,730 | 1.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.4M | 65,552 | 1.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $6.8M | 935,894 | 1.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.2M | 290,197 | 1.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $4.6M | 639,974 | 1.1% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $4.4M | $4,000,000 | 1.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.4M | 704,500 | 1.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.3M | 1,704,232 | 1.0% |
| Alector Inc(ALEC) | COM | 014442107 | $4.1M | 912,928 | 1.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $4.0M | 1,050,709 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.9M | 253,217 | 0.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.2M | 130,175 | 0.8% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.2M | 15,900 | 0.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.1M | 67,754 | 0.7% |
| Acelyrin Inc | COM | 00445A100 | $3.1M | 693,609 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.9M | 120,700 | 0.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.8M | 207,427 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.5M | 274,165 | 0.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.5M | 122,200 | 0.6% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $2.3M | 231,634 | 0.6% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.2M | 1,222,358 | 0.5% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.1M | 144,360 | 0.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $2.0M | 239,194 | 0.5% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $1.9M | 124,479 | 0.5% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.8M | 297,655 | 0.4% |
| Inogen Inc(INGN) | COM | 45780L104 | $1.7M | 208,790 | 0.4% |
| Immatics NV(IMTX) | SHS | N44445109 | $1.7M | 145,000 | 0.4% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $1.6M | 895,200 | 0.4% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $1.5M | 905,582 | 0.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $1.5M | 243,210 | 0.4% |